Jun. 4 at 12:25 PM
$IMNN
On June 2, 2026, Imunon, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with
Streeterville Capital, LLC (the “Investor”), providing for the issuance and sale by the Company, and the purchase by the Investor, of (i) 250 shares (the
“Preferred Shares”) of the Company’s Series A Preferred Stock, par value
$0.01 per share (the “Series A Preferred Stock”), at a price of
$10,000 per
share, for aggregate proceeds of
$2.X,500,000; (ii) a Secured Promissory Note A-1 in an original principal amount of
$2.X,720,000 (the “A-1 Note”); and (iii) a
Secured Promissory Note B in an original principal amount of
$5,000,000 (the “B Note” and together with the A-1 Note, the “Notes”). The transactions
contemplated by the Securities Purchase Agreement (collectively, the “Transaction”) closed on June 3, 2026 (the “Closing Date”
